REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Keymed Biosciences Inc. (Hong Kong) (Hong Kong SAR, China)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Keymed Biosciences Inc. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Keymed Biosciences Inc. focuses on the independent discovery and development of innovative biotherapy to meet the unmet medical needs in the field of autoimmune and tumor treatment. The company was founded in 2018 and is headquartered in Chengdu, China.

Headquarters
Building D2, No. 18 Biotown Middle Road, Tianfu International Biotown
Chengdu; Sichuan; Postal Code: 610219

Contact Details: Purchase the Keymed Biosciences Inc. (Hong Kong) report to view the information.

Website: http://www.keymedbio.com

Basic Information
Total Employees:
Purchase the Keymed Biosciences Inc. (Hong Kong) report to view the information.
Outstanding Shares:
Purchase the Keymed Biosciences Inc. (Hong Kong) report to view the information.
Registered Capital:
Purchase the Keymed Biosciences Inc. (Hong Kong) report to view the information.
Financial Auditors:
Purchase the Keymed Biosciences Inc. (Hong Kong) report to view the information.
Incorporation Date:
April 23, 2018
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Senior Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
27.86%
Purchase this report to view the information.
9.26%
Purchase this report to view the information.
5.85%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Beijing Lingyue Biomedical Technology Co., Ltd (China)
100%
Chengdu Huamian Biotechnology Co., Ltd. (China)
100%
Kangnuo Boyu Biomedical Technology (Chengdu) Co.,Ltd. (China)
100%
Company Performance
Financial values in the chart are available after Keymed Biosciences Inc. (Hong Kong) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-83.28%▼
Total operating revenue
-77.01%▼
Operating profit (EBIT)
-2266.7%▼
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-6.45%▼
Total equity
-21.85%▼
Operating Profit Margin (ROS)
-675.19%▼
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
18.67%▲
Quick Ratio
-8.56%▼
Cash Ratio
-3.6%▼

Similar companies

Ascletis Pharma Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo